Nuance Pharma
PrivateLast Round
Series E
Jul 22, 2025
Est. Valuation
$620.7M
Total Funding Raised
$216M
Company Overview
Nuance Pharma is a specialty pharmaceutical company that develops and commercializes innovative therapies for respiratory, emergency care, iron deficiency anemia, and pain management.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nuance Pharma Comparables
Compare Nuance Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SciClone Pharmaceuticals (Holdings) Limited | 70% | |
| Zai Lab Limited | 69% | |
| Stallergenes Greer | 67% | |
Nuance Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Jul 22, 2025 | ||||
| Strategic | Jun 10, 2021 | ||||
| Series D | Dec 8, 2020 | ||||
| Series B | Jun 27, 2018 |
Key People
Founding team and executive leadership
Nuance Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CBC Group | Series D, Series B |
| HBM Healthcare Investments | Series D, Series B |
| MPC | Series D |
| RTW Investments | Series D |
| nebag ag | Series B |
| HBM Partners | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2024
Ohtuvayre launched via early access in Hainan Boao Pilot Zone.
- Jun 10, 2021
$15M raised with Verona Pharma plc
Nuance Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nuance Pharma's valuation, stock price, and market status.